ArticleOncotarget2016

Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab.

Rika Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.